The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Arbidol Tablets (COVID-19) Market Research Report 2025
Synopsis
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
The global Arbidol Tablets (COVID-19) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.
This report aims to provide a comprehensive presentation of the global market for Arbidol Tablets (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arbidol Tablets (COVID-19).
Report Scope
The Arbidol Tablets (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Arbidol Tablets (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arbidol Tablets (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
Segment by Type
50mg
100mg
Segment by Application
Anti Influenza Virus
COVID-19
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Arbidol Tablets (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Arbidol Tablets (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
The global Arbidol Tablets (COVID-19) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.
This report aims to provide a comprehensive presentation of the global market for Arbidol Tablets (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arbidol Tablets (COVID-19).
Report Scope
The Arbidol Tablets (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Arbidol Tablets (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arbidol Tablets (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
Segment by Type
50mg
100mg
Segment by Application
Anti Influenza Virus
COVID-19
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Arbidol Tablets (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Arbidol Tablets (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Arbidol Tablets (COVID-19) Market Overview
1.1 Product Overview and Scope of Arbidol Tablets (COVID-19)
1.2 Arbidol Tablets (COVID-19) Segment by Type
1.2.1 Global Arbidol Tablets (COVID-19) Market Value Comparison by Type (2024-2030)
1.2.2 50mg
1.2.3 100mg
1.3 Arbidol Tablets (COVID-19) Segment by Application
1.3.1 Global Arbidol Tablets (COVID-19) Market Value by Application: (2024-2030)
1.3.2 Anti Influenza Virus
1.3.3 COVID-19
1.4 Global Arbidol Tablets (COVID-19) Market Size Estimates and Forecasts
1.4.1 Global Arbidol Tablets (COVID-19) Revenue 2019-2030
1.4.2 Global Arbidol Tablets (COVID-19) Sales 2019-2030
1.4.3 Global Arbidol Tablets (COVID-19) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Arbidol Tablets (COVID-19) Market Competition by Manufacturers
2.1 Global Arbidol Tablets (COVID-19) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Arbidol Tablets (COVID-19) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Arbidol Tablets (COVID-19) Average Price by Manufacturers (2019-2024)
2.4 Global Arbidol Tablets (COVID-19) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Arbidol Tablets (COVID-19), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Arbidol Tablets (COVID-19), Product Type & Application
2.7 Arbidol Tablets (COVID-19) Market Competitive Situation and Trends
2.7.1 Arbidol Tablets (COVID-19) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Arbidol Tablets (COVID-19) Players Market Share by Revenue
2.7.3 Global Arbidol Tablets (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Arbidol Tablets (COVID-19) Retrospective Market Scenario by Region
3.1 Global Arbidol Tablets (COVID-19) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Arbidol Tablets (COVID-19) Global Arbidol Tablets (COVID-19) Sales by Region: 2019-2030
3.2.1 Global Arbidol Tablets (COVID-19) Sales by Region: 2019-2024
3.2.2 Global Arbidol Tablets (COVID-19) Sales by Region: 2025-2030
3.3 Global Arbidol Tablets (COVID-19) Global Arbidol Tablets (COVID-19) Revenue by Region: 2019-2030
3.3.1 Global Arbidol Tablets (COVID-19) Revenue by Region: 2019-2024
3.3.2 Global Arbidol Tablets (COVID-19) Revenue by Region: 2025-2030
3.4 North America Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.4.1 North America Arbidol Tablets (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Arbidol Tablets (COVID-19) Sales by Country (2019-2030)
3.4.3 North America Arbidol Tablets (COVID-19) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.5.1 Europe Arbidol Tablets (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Arbidol Tablets (COVID-19) Sales by Country (2019-2030)
3.5.3 Europe Arbidol Tablets (COVID-19) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.6.1 Asia Pacific Arbidol Tablets (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Arbidol Tablets (COVID-19) Sales by Country (2019-2030)
3.6.3 Asia Pacific Arbidol Tablets (COVID-19) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.7.1 Latin America Arbidol Tablets (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Arbidol Tablets (COVID-19) Sales by Country (2019-2030)
3.7.3 Latin America Arbidol Tablets (COVID-19) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.8.1 Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Arbidol Tablets (COVID-19) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Arbidol Tablets (COVID-19) Sales by Type (2019-2030)
4.1.1 Global Arbidol Tablets (COVID-19) Sales by Type (2019-2024)
4.1.2 Global Arbidol Tablets (COVID-19) Sales by Type (2025-2030)
4.1.3 Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2019-2030)
4.2 Global Arbidol Tablets (COVID-19) Revenue by Type (2019-2030)
4.2.1 Global Arbidol Tablets (COVID-19) Revenue by Type (2019-2024)
4.2.2 Global Arbidol Tablets (COVID-19) Revenue by Type (2025-2030)
4.2.3 Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2019-2030)
4.3 Global Arbidol Tablets (COVID-19) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Arbidol Tablets (COVID-19) Sales by Application (2019-2030)
5.1.1 Global Arbidol Tablets (COVID-19) Sales by Application (2019-2024)
5.1.2 Global Arbidol Tablets (COVID-19) Sales by Application (2025-2030)
5.1.3 Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2019-2030)
5.2 Global Arbidol Tablets (COVID-19) Revenue by Application (2019-2030)
5.2.1 Global Arbidol Tablets (COVID-19) Revenue by Application (2019-2024)
5.2.2 Global Arbidol Tablets (COVID-19) Revenue by Application (2025-2030)
5.2.3 Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2019-2030)
5.3 Global Arbidol Tablets (COVID-19) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 JSC Pharmstandard
6.1.1 JSC Pharmstandard Corporation Information
6.1.2 JSC Pharmstandard Description and Business Overview
6.1.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Product Portfolio
6.1.5 JSC Pharmstandard Recent Developments/Updates
6.2 Jiangsu Wuzhong Pharmaceutical
6.2.1 Jiangsu Wuzhong Pharmaceutical Corporation Information
6.2.2 Jiangsu Wuzhong Pharmaceutical Description and Business Overview
6.2.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
6.2.5 Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
6.3 CSPC Ouyi Pharmaceutical
6.3.1 CSPC Ouyi Pharmaceutical Corporation Information
6.3.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.3.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
6.3.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.4 Simcere Pharmaceutical
6.4.1 Simcere Pharmaceutical Corporation Information
6.4.2 Simcere Pharmaceutical Description and Business Overview
6.4.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
6.4.5 Simcere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Arbidol Tablets (COVID-19) Industry Chain Analysis
7.2 Arbidol Tablets (COVID-19) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Arbidol Tablets (COVID-19) Production Mode & Process
7.4 Arbidol Tablets (COVID-19) Sales and Marketing
7.4.1 Arbidol Tablets (COVID-19) Sales Channels
7.4.2 Arbidol Tablets (COVID-19) Distributors
7.5 Arbidol Tablets (COVID-19) Customers
8 Arbidol Tablets (COVID-19) Market Dynamics
8.1 Arbidol Tablets (COVID-19) Industry Trends
8.2 Arbidol Tablets (COVID-19) Market Drivers
8.3 Arbidol Tablets (COVID-19) Market Challenges
8.4 Arbidol Tablets (COVID-19) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Arbidol Tablets (COVID-19) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Arbidol Tablets (COVID-19) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Arbidol Tablets (COVID-19) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Arbidol Tablets (COVID-19) Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Arbidol Tablets (COVID-19) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Arbidol Tablets (COVID-19) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Arbidol Tablets (COVID-19) Average Price (US$/K Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Arbidol Tablets (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Arbidol Tablets (COVID-19), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Arbidol Tablets (COVID-19), Product Type & Application
Table 12. Global Key Manufacturers of Arbidol Tablets (COVID-19), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Arbidol Tablets (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arbidol Tablets (COVID-19) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Arbidol Tablets (COVID-19) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Arbidol Tablets (COVID-19) Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Arbidol Tablets (COVID-19) Sales Market Share by Region (2019-2024)
Table 19. Global Arbidol Tablets (COVID-19) Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Arbidol Tablets (COVID-19) Sales Market Share by Region (2025-2030)
Table 21. Global Arbidol Tablets (COVID-19) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Arbidol Tablets (COVID-19) Revenue Market Share by Region (2019-2024)
Table 23. Global Arbidol Tablets (COVID-19) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Arbidol Tablets (COVID-19) Revenue Market Share by Region (2025-2030)
Table 25. North America Arbidol Tablets (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Arbidol Tablets (COVID-19) Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Arbidol Tablets (COVID-19) Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Arbidol Tablets (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Arbidol Tablets (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Arbidol Tablets (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Arbidol Tablets (COVID-19) Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Arbidol Tablets (COVID-19) Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Arbidol Tablets (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Arbidol Tablets (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Arbidol Tablets (COVID-19) Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Arbidol Tablets (COVID-19) Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Arbidol Tablets (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Arbidol Tablets (COVID-19) Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Arbidol Tablets (COVID-19) Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Arbidol Tablets (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Arbidol Tablets (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Arbidol Tablets (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Arbidol Tablets (COVID-19) Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Arbidol Tablets (COVID-19) Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Arbidol Tablets (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Arbidol Tablets (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Type (2019-2024)
Table 51. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Type (2025-2030)
Table 52. Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2019-2024)
Table 53. Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2025-2030)
Table 54. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2019-2024)
Table 57. Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2025-2030)
Table 58. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Type (2019-2024)
Table 59. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Type (2025-2030)
Table 60. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Application (2019-2024)
Table 61. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Application (2025-2030)
Table 62. Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2019-2024)
Table 63. Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2025-2030)
Table 64. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2019-2024)
Table 67. Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2025-2030)
Table 68. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Application (2019-2024)
Table 69. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Application (2025-2030)
Table 70. JSC Pharmstandard Corporation Information
Table 71. JSC Pharmstandard Description and Business Overview
Table 72. JSC Pharmstandard Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2019-2024)
Table 73. JSC Pharmstandard Arbidol Tablets (COVID-19) Product
Table 74. JSC Pharmstandard Recent Developments/Updates
Table 75. Jiangsu Wuzhong Pharmaceutical Corporation Information
Table 76. Jiangsu Wuzhong Pharmaceutical Description and Business Overview
Table 77. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2019-2024)
Table 78. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product
Table 79. Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
Table 80. CSPC Ouyi Pharmaceutical Corporation Information
Table 81. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 82. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2019-2024)
Table 83. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product
Table 84. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 85. Simcere Pharmaceutical Corporation Information
Table 86. Simcere Pharmaceutical Description and Business Overview
Table 87. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2019-2024)
Table 88. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product
Table 89. Simcere Pharmaceutical Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Arbidol Tablets (COVID-19) Distributors List
Table 93. Arbidol Tablets (COVID-19) Customers List
Table 94. Arbidol Tablets (COVID-19) Market Trends
Table 95. Arbidol Tablets (COVID-19) Market Drivers
Table 96. Arbidol Tablets (COVID-19) Market Challenges
Table 97. Arbidol Tablets (COVID-19) Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Arbidol Tablets (COVID-19)
Figure 2. Global Arbidol Tablets (COVID-19) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Arbidol Tablets (COVID-19) Market Share by Type in 2023 & 2030
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Arbidol Tablets (COVID-19) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Arbidol Tablets (COVID-19) Market Share by Application in 2023 & 2030
Figure 8. Anti Influenza Virus
Figure 9. COVID-19
Figure 10. Global Arbidol Tablets (COVID-19) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Arbidol Tablets (COVID-19) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Arbidol Tablets (COVID-19) Sales (2019-2030) & (M Pcs)
Figure 13. Global Arbidol Tablets (COVID-19) Average Price (US$/K Pcs) & (2019-2030)
Figure 14. Arbidol Tablets (COVID-19) Report Years Considered
Figure 15. Arbidol Tablets (COVID-19) Sales Share by Manufacturers in 2023
Figure 16. Global Arbidol Tablets (COVID-19) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Arbidol Tablets (COVID-19) Players: Market Share by Revenue in 2023
Figure 18. Arbidol Tablets (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Arbidol Tablets (COVID-19) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Arbidol Tablets (COVID-19) Sales Market Share by Country (2019-2030)
Figure 21. North America Arbidol Tablets (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 22. United States Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Arbidol Tablets (COVID-19) Sales Market Share by Country (2019-2030)
Figure 25. Europe Arbidol Tablets (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Arbidol Tablets (COVID-19) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Arbidol Tablets (COVID-19) Revenue Market Share by Region (2019-2030)
Figure 33. China Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Arbidol Tablets (COVID-19) Sales Market Share by Country (2019-2030)
Figure 43. Latin America Arbidol Tablets (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Arbidol Tablets (COVID-19) Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Arbidol Tablets (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Arbidol Tablets (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Arbidol Tablets (COVID-19) by Type (2019-2030)
Figure 53. Global Revenue Market Share of Arbidol Tablets (COVID-19) by Type (2019-2030)
Figure 54. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Type (2019-2030)
Figure 55. Global Sales Market Share of Arbidol Tablets (COVID-19) by Application (2019-2030)
Figure 56. Global Revenue Market Share of Arbidol Tablets (COVID-19) by Application (2019-2030)
Figure 57. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Application (2019-2030)
Figure 58. Arbidol Tablets (COVID-19) Value Chain
Figure 59. Arbidol Tablets (COVID-19) Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
